{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:13:33Z","timestamp":1788286413121,"version":"build-2803163510"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-01809"],"award-info":[{"award-number":["2023-01809"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det om H\u00e4lsa, Arbetsliv och V\u00e4lf\u00e4rd","doi-asserted-by":"publisher","award":["2023-01221"],"award-info":[{"award-number":["2023-01221"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["24 3862 Pj"],"award-info":[{"award-number":["24 3862 Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["874662"],"award-info":[{"award-number":["874662"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020771","name":"Young Scientists Fund of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82404392"],"award-info":[{"award-number":["82404392"]}],"id":[{"id":"10.13039\/501100020771","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Investigator-initiated Trial Program of Shanghai Pudong New Area Health Commission","award":["2025-PWDL-12"],"award-info":[{"award-number":["2025-PWDL-12"]}]},{"name":"General Program of the Shanghai Pudong New Area Mental Health Center","award":["PDJWM-202501"],"award-info":[{"award-number":["PDJWM-202501"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["22120260181"],"award-info":[{"award-number":["22120260181"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The role of human papillomavirus (HPV) in cardiovascular disease (CVD) remains unclear. We aimed to investigate the associations of HPV infection with incident CVD and CVD-related mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      In this population-based matched cohort study based on Swedish national registers, we identified women with an incident HPV infection during 2006 and 2024 (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009497,445), and age-matched each woman with five women without infection. The time-varying associations between HPV infection and CVD were assessed using flexible parametric models, which also provided hazard ratios (HRs) and 95% confidence intervals (CIs) after adjusting for sociodemographic factors, HPV vaccination, chronic diseases, and parental history of related diseases. To control for familial factors, we also compared 143,787 women with HPV infection to their 174,637 unaffected full siblings.\n                    <\/jats:p>\n                    <jats:p>A total of 28,793 and 128,373 incident CVDs were identified in women with and without HPV infection (Incidence: 8.27 and 7.93 per 1,000 person-years), respectively. Additionally, 1,221 and 4,941 CVD-related deaths were observed among women with and without HPV infection (Mortality: 33.73 and 29.39 per 100,000 person-years), respectively. The risks of incident CVD and mortality were most pronounced within the first follow-up year and attenuated thereafter.<\/jats:p>\n                    <jats:p>Overall, women with HPV infection had an increased risk of incident CVD (adjusted HR 1.07, 95% CI [1.05, 1.08], absolute rate difference 0.53 per 1,000 person-years, population-attributable fraction 1.16%) and CVD-related mortality (adjusted HR 1.25, 95% CI [1.16, 1.34], absolute rate difference 6.71 per 100,000 person-years, population-attributable fraction 4.12%) than those without. During the first follow-up year, the adjusted HRs for incident CVD and CVD-related mortality were 1.43 (95% CI [1.38, 1.48]) and 1.86 (95% CI [1.41, 2.45]), respectively. Beyond the first follow-up year, the corresponding adjusted HRs decreased to 1.02 (95% CI [1.01, 1.04]) for incident CVD and 1.21 (95% CI [1.12, 1.30]) for CVD-related mortality. In sibling comparisons, positive associations with both outcomes were also observed. Women with HPV infection had fully adjusted HRs of 1.05 (95% CI [1.01, 1.08]) for incident CVD and 1.25 (95% CI [1.01, 1.53]) for CVD-related mortality compared to their siblings without HPV infections.<\/jats:p>\n                    <jats:p>The main limitations of this study are its observational design, which precludes causal inference between HPV infection and CVD, and the potential misclassification of HPV infection, which may have biased the association towards the null.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HPV infection was associated with increased risk of incident CVD and CVD-related mortality. The findings suggested that clinicians should be aware of a slightly elevated CVD risk in women with HPV, especially during the first year following an infection. However, given the small absolute difference, women should not be unduly concerned.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1005222","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:22:41Z","timestamp":1788283361000},"page":"e1005222","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human papillomavirus infection and risk of cardiovascular disease: A population-based matched cohort study with sibling analysis"],"prefix":"10.1371","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4848-2953","authenticated-orcid":true,"given":"Yunyang","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4518-5670","authenticated-orcid":true,"given":"Mark","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2713-8657","authenticated-orcid":true,"given":"Chaonan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-5602","authenticated-orcid":true,"given":"Jonas F.","family":"Ludvigsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7214-4797","authenticated-orcid":true,"given":"Qing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4718-1414","authenticated-orcid":true,"given":"Jiayao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"pmed.1005222.ref001","unstructured":"World Health Organization (WHO). Cardiovascular diseases (CVDs). Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds). 2021. Accessed 2026 May 12."},{"issue":"5","key":"pmed.1005222.ref002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.31083\/j.rcm2405134","article-title":"Non-traditional risk factors as contributors to cardiovascular disease","volume":"24","author":"L Wang","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"pmed.1005222.ref003","article-title":"The biology and life-cycle of human papillomaviruses","author":"J Doorbar","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"pmed.1005222.ref004","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"C de Martel","year":"2017","journal-title":"Int J Cancer"},{"issue":"12","key":"pmed.1005222.ref005","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s10096-018-3370-z","article-title":"Viral infection and atherosclerosis","volume":"37","author":"N Hemmat","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"pmed.1005222.ref006","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/eurheartj\/ehae020","article-title":"Human papillomavirus infection and cardiovascular mortality: a cohort study","volume":"45","author":"HS Cheong","year":"2024","journal-title":"Eur Heart J"},{"issue":"5","key":"pmed.1005222.ref007","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/CIRCRESAHA.118.313779","article-title":"High-risk human papillomavirus infection and the risk of cardiovascular disease in Korean women","volume":"124","author":"E-J Joo","year":"2019","journal-title":"Circ Res"},{"issue":"3","key":"pmed.1005222.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2022.09.021","article-title":"The effects of human papillomavirus infection and vaccination on cardiovascular diseases, NHANES 2003-2016","volume":"136","author":"X Liang","year":"2023","journal-title":"Am J Med"},{"key":"pmed.1005222.ref009","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/CLEP.S314959","article-title":"Nordic health registry-based research: a review of health care systems and key registries","volume":"13","author":"K Laugesen","year":"2021","journal-title":"Clin Epidemiol"},{"key":"pmed.1005222.ref010","unstructured":"Annual reports from NKCx. Available from: https:\/\/nkcx.se\/report_general_e.html. Accessed 2026 March 25."},{"issue":"4","key":"pmed.1005222.ref011","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0969141316632023","article-title":"Registry-based assessment of the status of cervical screening in Sweden","volume":"23","author":"KM Elfstr\u00f6m","year":"2016","journal-title":"J Med Screen"},{"issue":"11","key":"pmed.1005222.ref012","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"JF Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"pmed.1005222.ref013","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"JF Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"9","key":"pmed.1005222.ref014","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"HL Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"pmed.1005222.ref015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","volume":"48","author":"L Barlow","year":"2009","journal-title":"Acta Oncol"},{"issue":"2","key":"pmed.1005222.ref016","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamaoncol.2025.5511","article-title":"Quadrivalent human papillomavirus vaccine and high-grade vulvovaginal lesions","volume":"12","author":"Y Deng","year":"2026","journal-title":"JAMA Oncol"},{"issue":"1","key":"pmed.1005222.ref017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10654-022-00947-5","article-title":"The Swedish medical birth register during five decades: documentation of the content and quality of the register","volume":"38","author":"S Cnattingius","year":"2023","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"pmed.1005222.ref018","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"JF Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"pmed.1005222.ref019","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research","volume":"34","author":"JF Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"pmed.1005222.ref020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-59745-423-0_10","article-title":"The Swedish multi-generation register","volume":"675","author":"A Ekbom","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"5","key":"pmed.1005222.ref021","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ijc.32416","article-title":"Cervical cancer case-control audit: results from routine evaluation of a nationwide cervical screening program","volume":"146","author":"J Wang","year":"2020","journal-title":"Int J Cancer"},{"key":"pmed.1005222.ref022","article-title":"Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study","volume":"365","author":"H Song","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"pmed.1005222.ref023","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"E Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"issue":"19","key":"pmed.1005222.ref024","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.jacc.2011.07.038","article-title":"Human papillomavirus and cardiovascular disease among U.S. women in the National Health and Nutrition Examination Survey, 2003 to 2006","volume":"58","author":"HK Kuo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"pmed.1005222.ref025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2147\/CLEP.S90589","article-title":"Ethical aspects of registry-based research in the Nordic countries","volume":"7","author":"JF Ludvigsson","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"9596","key":"pmed.1005222.ref026","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"E von Elm","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"pmed.1005222.ref027","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrcardio.2012.45","article-title":"Stress and cardiovascular disease","volume":"9","author":"A Steptoe","year":"2012","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"pmed.1005222.ref028","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.07-0036","article-title":"Depression, anxiety, and quality of life in patients with atrial fibrillation","volume":"132","author":"G Thrall","year":"2007","journal-title":"Chest"},{"issue":"7","key":"pmed.1005222.ref029","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1007\/s11010-025-05236-9","article-title":"Exploring the potential link between human papillomavirus infection and coronary artery disease: a review of shared pathways and mechanisms","volume":"480","author":"D Saha","year":"2025","journal-title":"Mol Cell Biochem"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1005222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:22:50Z","timestamp":1788283370000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1005222"}},"subtitle":[],"editor":[{"given":"Pei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1005222","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}